CV Sciences, Inc. Announces Launch of PlusCBD™ Pet Product Line
Full line of soothing hemp extracts formulated exclusively for dogs and cats
November 04, 2020 07:00 ET | Source: CV Sciences, Inc. CV Sciences, Inc.
San Diego, California, UNITED STATES
SAN DIEGO, Nov. 04, 2020 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of PlusCBD™ Pet, a full line of hemp extracts formulated exclusively for dogs and cats.
Made with the same trusted hemp extracts used in CV Sciences’ best-selling CBD products, PlusCBD™ Pet is available in 250mg and 500mg formats with pet friendly flavors, including beef, chicken, peanut butter and salmon, as well as unflavored. PlusCBD™ Pet will be sold across the Company’s natural and online retail channels, with plans to expand into the pet specialty channel and food, drug and mass retail channel.
The U.S. Pet CBD market grew to over 10 times its 2018 size in 2019, producing $321 million in sales, and is projected to reach $563 million by the end of 2020, according to Brightfield Group. Growth is being driven by pet owners looking for natural alternatives for pets’ medical ailments, including anxiety, pain, or other serious conditions that have not responded well to other treatments, and is expected to make up a $1.7 billion market by the end of 2025, based on Brightfield Group data.
“PlusCBD™ Pet provides us with an exciting opportunity to leverage our brand equity and retail distribution channels to participate in the growing pet CBD market,” said Joseph Dowling, Chief Executive Officer, CV Sciences. “We believe the pet CBD category will continue to grow as more research demonstrates the health benefits of CBD for dogs and cats. Our employees have supplemented their pets with our human PlusCBD™ products for years, now we are pleased to have an opportunity to help all pet parents love their pets with our soothing PlusCBD™ Pet products formulated specifically for animals.”
About CV Sciences, Inc.
CV, or Curriculum Vitae, is Latin for “course of life”, and science is the pursuit of truth. CV Sciences: our name is our mission — improving quality of life through nature and science.
CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based dietary supplements and CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics. The Company’s PlusCBD™ products are sold at more than 6,200 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences follows all guidelines for Good Manufacturing Practices (GMP) and the Company’s products are processed, produced, and tested throughout the manufacturing process to confirm strict compliance with company standards and specifications. With a commitment to science, PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. PlusCBD™ was the first hemp CBD supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. CV Sciences, Inc. has primary offices and facilities in San Diego, California. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
Scott Van Winkle
PlusCBD™ Pet Product Line Full line of soothing hemp extracts formulated exclusively for dogs and cats
CBD Doses for Dogs or Cats
Whether you’re using hemp CBD oil for anxiety or pain relief, the right dose can vary quite a bit from one situation to the next and you may need to experiment to find the right amount and how often. Start with a dose in the middle of the range and expect to see results in 30–60 minutes. If there is no change after an hour, increase the dosage.
Affordable CBD for dogs and cats
Wisely Pet’s hemp CBD products are among the highest quality and most affordable CBD options available for dogs and cats. To make long-term use affordable or to give CBD to larger dogs, you may want to compare CBD prices. Each product has a specific set of benefits–feel free to use our web chat or email us at [email protected] if you would like a recommendation for your pet. Our highly-trained pet care specialists will be happy to help you find the best CBD for your dog or cat.
What’s the right CBD dose for your cat or dog?
The basic dosing rule for cats and dogs: 1–5 mg CBD for every 10 pounds of body weight.
Because potencies vary by CBD product, it’s important to read the label to determine the amount of CBD to offer, not focus on the volume of the product it’s in.
How often should you give your dog or cat CBD?
To control pain, give your dog or cat CBD every 8 hours or as needed. For other uses, give once or twice a day.